Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
Product Classification
Formulation Information
TABLET, SUGAR COATED
**Dosage and Administration** Adults (including the elderly) : 1 tablet 3 times daily.
ORAL
Medical Information
**Indications** Symptomatic relief of dysuria, urgency, nocturia, vesical suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis and urethrotrigonitis.
**Contraindications** Patients who have any of the following obstructive conditions : Pyloric or duodenal obstruction, obstructive intestinal lesions or ileus, achalasia, gastrointestinal haemorrhage and obstructive uropathies of the lower urinary tract.
G04BD02
flavoxate
Manufacturer Information
ZYFAS PHARMA PTE. LTD.
SAM CHUN DANG PHARM CO LTD
Active Ingredients
Documents
Package Inserts
1.4.3 SIN Cleanxate tab. insert_211103 Clean.pdf
Approved: January 19, 2022